HopeStage
Back to all studies
CompletedNCT02768441

Dexamphetamine Blood Levels Measured With Dried Blood Spots

About this titleRead the official source — NCT02768441
Medication studyAges 25+NetherlandsAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 25 years.

Listed locations
AmsterdamSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 1, 2016
Recruitment status
Completed
Enrollment listed in the registry
12
Sponsor
The Netherlands Cancer Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
Netherlands
Age range
Over 25 Years
Official registry ID
NCT02768441
Official title
Show the full official title

Pharmacokinetics of New Dexamphetamine Sustained Release Tablets and the Clinical Validation of Measuring Dexamphetamine in Dried Blood Spots

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Amsterdam

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The Netherlands Cancer Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Dexamphetamine.

Who was this study for?

Listed age limits: from 25 years.

Want to explore more studies?

Explore studies